We recently demonstrated cAMP activation of Epac-Rap1A and RhoA-Rho-associated kinase (ROCK)-F-actin signaling in arteriolar-derived smooth muscle cells increases expression and cell surface translocation of functional ␣ 2C-adrenoceptors (␣ 2C-ARs) that mediate vasoconstriction in small blood vessels (arterioles). The Ras-related small GTPAse Rap1A increased expression of ␣ 2C-ARs and also increased translocation of perinuclear ␣ 2C-ARs to intracellular F-actin and to the plasma membrane. This study examined the mechanism of translocation to better understand the role of these newly discovered mediators of blood flow control, potentially activated in peripheral vascular disorders. We utilized a yeast two-hybrid screen with human microvascular smooth muscle cells (microVSM) cDNA library and the ␣ 2C-AR COOH terminus to identify a novel interaction with the actin cross-linker filamin-2. Yeast ␣-galactosidase assays, site-directed mutagenesis, and coimmunoprecipitation experiments in heterologous human embryonic kidney (HEK) 293 cells and in human microVSM demonstrated that ␣ 2C-ARs, but not ␣ 2A-AR subtype, interacted with filamin. In Rap1-stimulated human microVSM, ␣ 2C-ARs colocalized with filamin on intracellular filaments and at the plasma membrane. Small interfering RNA-mediated knockdown of filamin-2 inhibited Rap1-induced redistribution of ␣ 2C-ARs to the cell surface and inhibited receptor function. The studies suggest that cAMP-Rap1-Rho-ROCK signaling facilitates receptor translocation and function via phosphorylation of filamin-2 Ser 2113 . Together, these studies extend our previous findings to show that functional rescue of ␣ 2C-ARs is mediated through Rap1-filamin signaling. Perturbation of this signaling pathway may lead to alterations in ␣ 2C-AR trafficking and physiological function.
tors have a unique mechanism of regulation compared with the other two family members, the ␣ 2A -ARs and ␣ 2B -ARs. ␣ 2C -ARs are generally retained in intracellular Golgi compartment and are silent but can translocate to the cell surface under vascular stress, including cold exposure, and elicit a functional response leading to vasoconstriction (7, 8, 18, 20) . It is therefore important to understand the mechanisms of receptor expression and trafficking for a clear understanding of ␣ 2C -AR physiology and its role in pathobiology.
We recently demonstrated a role of the Ras-related small GTPase Rap1A in enhancing translocation of ␣ 2C -ARs from the perinuclear compartment to the cell surface of microvascular smooth muscle cells (microVSM; Ref. 19) . In human microVSM, increased levels of intracellular cAMP or exogenous addition of the cAMP analog 8-pCPT-2=-O-cAMP activated Rap1, leading to subsequent activation of RhoA, Rhoassociated kinase (ROCK), and increase in F-actin (8, 19) . This increased F-actin facilitated cell surface receptor translocation on actin filaments, which was disrupted by the actin destabilizing agents cytochalasin D or latrunculin A (19) . These studies demonstrated that functional rescue of ␣ 2C -ARs is not restricted to cold exposure but can also occur at physiological temperatures (temperature-independent). The goal of the present study, therefore, was to identify the mechanism(s) involved. In this study, we used the ␣ 2C -AR carboxy terminus (last 20 amino acids) as bait in a yeast two-hybrid genetic screen and identified a novel interaction with the actin crosslinker filamin-2. The ␣ 2C -AR but not the ␣ 2A -AR subtype interacted with filamin. Our results also suggest that the phosphorylation of filamin-2 at Ser 2113 by Rap1A-Rho-ROCK is necessary for receptor translocation.
These studies show that Rap1-filamin signaling regulates redistribution of ␣ 2C -ARs and show that functional rescue of ␣ 2C -ARs can occur at normal temperatures via this pathway. These findings suggest that loss-of-function genetic mutations in filamin may lead to reduced ␣ 2C -AR trafficking, affecting physiological function. Alternatively, gain-of-function due to activation of this signaling pathway during vascular stress may lead to increased ␣ 2C -AR biological activity and vascular reactivity. Together, these studies provide insights into the mechanism of G protein-coupled receptor (GPCR) trafficking.
Adenovirus Constructs
The Rap1A-63E (constitutively active; Ad-Rap1A-CA) and vector-CMV backbone without insert (Ad-Control) were generated by the method described by He et al. (15) and optimized for microVSM delivery as previously described (9, 19) . All experimental studies with adenovirus were performed according to National Institutes of Health Guidelines and Institutional Biological and Chemical Safety Committee guidelines and approved protocols.
Site-Directed Mutagenesis
Site-directed mutagenesis was performed using mutant oligonucleotide primers and double stranded DNA using the QuickChange XL site-directed mutagenesis kit (Stratagene, La Jolla, CA). The five arginines (R 454Ϫ458 ) in the COOH terminus of the ␣2C-AR were mutated to alanines (A 454 -458 ). The mutated construct (referred to as ␣2C-AR-1-5 MUT) generated by this approach was examined for any gross deletions by restriction enzyme digestions and agarose gel analyses, and the mutations were confirmed by DNA sequencing.
Antibodies 1)
Anti-␣ 2C-AR affinity purified rabbit polyclonal antibody. This antibody recognizes the carboxy terminus of ␣2C-ARs. The specificity of this antibody for Western blot analysis and imaging has been established in published studies. (2, 9, 19) . This antibody recognizes the ϳ70-kDa mature receptor form that translocates from the Golgi compartment to the cell surface (18) .
2) Anti-human filamin (monoclonal, purified by protein A affinity chromatography, clone 1.BB.804) was purchased from US Biological Biochemicals and Biological Reagents (Swampscott, MA).
3) Anti-human and murine filamin-2 phospho-Ser 2113 -specific antibody (rabbit polyclonal, purified by affinity chromatography) was purchased from Invitrogen (Camarillo, CA).
4) Anti-␤-actin was purchased from Sigma-Aldrich (clone AC-15). 5) Anti-HA.11 monoclonal antibody (clone 16B12) was purchased from Covance (Berkeley, CA).
6) Anti-aequorea victoria GFP affinity-purified monoclonal antibody (JL-8) was purchased from Clontech (Mountain View, CA).
7) Normal IgG (rabbit and mouse) used as negative control IgG for coimmunoprecipitation (Co-IP) studies was purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
All secondary horseradish peroxidase-or alkaline phosphataselabeled (anti-mouse and anti-rabbit) antibodies were purchased from GE Healthcare/Amersham (Pittsburgh, PA) or Jackson ImmunoResearch Laboratories (West Grove, PA).
Chemicals 1)
Forskolin: this adenylyl cyclase activator, derived from Coleus forskohlii and Ն98% pure, was obtained in powder form from Sigma (St. Louis, MO). Working stock solutions of 10 mM were made by dissolving in DMSO solvent.
2) 8-(4-chlorophenylthio)-2=-O-methyl-cAMP (abbreviated 8-pCPT-2=-O-Me-cAMP): 5-mol aliquots of this membrane-permeant Epac-Rap activator were purchased from BIOLOG Life Science Institute (Bremen, Germany) and reconstituted in 50 l of sterile distilled, deionized water to give 100 mM stocks.
3) Fasudil hydrochloride [1-(5-isoquinolinesulfonyl)-homopiperazine hydrochloride; Tocris Bioscience, Ellisville, MO]: fresh stocks (10 mM) of this ROCK inhibitor were prepared in sterile distilled, deionized water before each experiment.
Yeast Two-Hybrid Screen
The last 37 amino acids of ␣ 2C-AR, including part of transmembrane 7 and carboxy terminus (amino acids 426 -462), or the last 20 amino acids (443-462), or the last 36 amino acids of ␣ 2A-AR (415-450) were amplified by PCR (Platinum Taq DNA polymerase, high-fidelity, Invitrogen) using primers containing restriction enzyme sites (NcoI, forward primer, and BamHI, reverse primer). The gelpurified PCR product was digested with NcoI-BamHI and inserted downstream in-frame with the Gal4 DNA-binding domain in the bait vector pGBKT7 (Clontech, Palo Alto, CA), also digested with NcoIBamHI. The constructs were confirmed to be error-free and in-frame by DNA sequencing.
The MATCHMAKER library construction kit (Clontech Laboratories, Mountain View, CA) was used to generate a cDNA expression library using polyA mRNA isolated from serum-induced (10% FBS, 12 h) microVSM. (FastTrack 2.0 kit for isolation of mRNA; Invitrogen). Cloning of cDNA inserts in vector pGADT7 allowed expression as a fusion to GAL4 activation domain. Yeast two-hybrid screening was performed according to manufacturer's protocol (Clontech) using the last 20 amino acids of ␣ 2C-AR as bait. Approximately 1.04 ϫ 10 5 clones were screened. As previously demonstrated by us these microVSM have inducible, plasma membrane-associated endogenous ␣ 2C-ARs (8, 9, 19) , and harbor physiologically relevant proteinprotein interactions with correct stoichiometry.
Yeast Two-Hybrid ␣-Galactosidase Assays
These assays were performed according to the manufacturer recommendations (Clontech) using filamin-2 fragment (aa 1979 -2206), and ␣ 2A-AR (aa 415-450), ␣2C-AR [aa 426 -462, wild type (WT)], or ␣2C-AR [aa 426 -462, mutant (MUT)] fused in frame to the GAL4 DNA-binding domain. Positive controls included p53-SV40 T antigen. Selection was performed on media deficient in amino acids histidine, leucine, and tryptophan. Under these conditions, proteinprotein interactions would lead to survival on selection media and to colony growth.
Human and Murine VSM Culture
Human arteriolar VSM cells explanted from dermal arterioles of healthy volunteers, and murine VSM derived from tail arteries of C57BL/6J WT mice (control) or mice deficient in the Ras-related GTPase Rap1A (Rap1A-null; referred to as microVSM) were used for the studies as previously described (9, 19) . The studies performed on human tissue were approved by the Biomedical Sciences Institutional Review Board of Ohio State University, and the studies performed on murine tissue were approved by the Institutional Animal Care and Use Committees of the Ohio State University and the Research Institute at Nationwide Children's Hospital.
Amaxa nucleofections. Amaxa nucleofections (Amaxa, Gaithersburg, MD) were performed for delivery of plasmid DNA to human microVSM as previously described (12, 19) . Transfected cells were subsequently washed once with serum-depleted medium (0.5% Hams), quiesced in 0.5% Ham's for 48 -72 h, followed by solvent (DMSO, H 2O), forskolin (10 M), or 8-pCPT-2=-O-Me-cAMP (100 M) treatments for indicated times.
Co-IP and Immunoflurescence
Endogenous receptors. Cells were lysed in IP buffer (50 mM Tris/7.5, 0.25% sodium deoxycholate, 1% NP40, 150 mM NaCl, 1 mM EDTA, plus fresh protease and phosphatase inhibitors), sonicated (3 ϫ 10 s on ice), and centrifuged at 14,000 g, 10 min at 4°C. Protein estimations were performed on the supernatant, and 200 -450 g of total cell lysates were used to IP with antibodies (overnight at 4°C, with gentle rotation) against ␣ 2C-ARs (at 1:200 dilution) or against filamin (at 1:200 dilution). The target protein-antibody complex was pulled down with protein A/G agarose (Pierce Biotechnology, Rockford, IL) for 2 h at 4°C, and nonspecific binding was removed by three washes (1 ml each) with the same IP buffer. The beads were resus- . This repeat 20 region includes 78 amino acids of muscle-specific insert region and the phosphorylation site Ser 2113 . Phosphorylation of this conserved Ser 2113 has been shown to be necessary and sufficient for actin reorganization in non-VSM. HR, hinge region. B: quantitative yeast ␣-galactosidase assays were utilized to examine protein-protein interactions between filamin-2 fragment and ␣2A-and ␣2C-AR [wild-type (WT) or 1-5 mutant (MUT)] regions of interest. Gal 4 DNA-binding domain (DNA-BD) was fused to the last 36 amino acids of ␣2A-AR or the last 37 amino acids of ␣2C-AR, and expressed as fusion protein in the yeast strain AH109. Assays were performed on colonies selected on dropout selection medium-histidine/-leucine/-tryptophan. The ␣2C-AR WT or ␣2C-AR-1-5 MUT interaction with filamin-2 fragment was compared with ␣2A-AR WT and pGBKT7 backbone vector interactions with the same filamin-2 fragment. Similar results were observed when Gal4 DNA-BD was also fused to the last 20 amino acids of ␣2C-AR (amino acid residues in white). Positive control, p53-SV40 large T-antigen and negative control, lamin C (lam), and T antigen (undetectable, 0 on the x-axis). Data are presented as means Ϯ SE (n ϭ 6). *P Ͻ 0.05. pended in sample buffer (62.5 mM Tris·HCl, pH 6.8, 2% SDS, 10% glycerol, 50 mM DTT or 5% ␤-mercaptoethanol, 0.01% bromophenol blue), incubated at 37°C for 1 h, and used for Western blot analysis. Similarly, IP experiments were performed with IgG (mouse or rabbit) alone as control for antibody specificity.
Tagged receptors. Plasmids encoding HA-or GFP-tagged receptors were used. Amaxa nucleofected quiescent microVSM were treated with forskolin (10 M) for 16 h before harvesting cells for Co-IP studies. IP was performed as described above for endogenous receptors using 26 -80 g of total lysates and antibodies against HA (1:200, gentle rotation overnight) or GFP (1:200, gentle rotation overnight).
Measurement of intracellular cAMP. The intracellular cAMP levels in human microVSM were measured to assess endogenous ␣ 2C-AR cell surface association and function in the absence (solvent control) or presence of fasudil (3 M), control nonsilencing RNA [non-small interfering (si)RNA, non-siRNA], or filamin-2 silencing RNA (FLN-2 siRNA). Cyclic AMP levels were quantitated using ELISA (Enzo Life Sciences, Farmingdale, NY) as previously described (19) .
Human Embryonic Kidney 293 Studies
Cell culture and transient transfections. Human embryonic kidney (HEK) 293 cells from American Type Culture Collection (Manassas, VA) were utilized. Cells were grown in MEM supplemented with 10% heat-inactivated FBS, 2 mM L-glutamine, 1 mM sodium pyruvate, 1.5 g/l sodium bicarbonate, and without antibiotics and were routinely kept in a 37°C incubator with 5% CO 2. Transient cotransfections were performed as previously described (19) .
Co-IP studies. These studies utilized amino-terminal HA-tagged ␣ 2C-ARs, pcDNA (control empty vector), and Rap1A-CA. Co-IP was performed using the same buffer conditions described above for microVSM studies. The cell lysates were immunoprecipitated with HA and blotted with filamin. Similarly, IP experiments were performed with IgG (mouse) alone as control for antibody specificity.
Live-cell labeling studies. The amino-terminal HA-tagged ␣ 2C-ARs were utilized for transient transfections and allowed quantitation of cell surface receptors by immunoprecipitation of the extracellular domain HA tag followed by Western blot analysis. The live-cell labeling was performed as previously described (19) .
For studies examining the role of filamin-2 in receptor mobilization, HEK293 cells were cotransfected with siRNAs and plasmid DNA using Lipofectamine 2000 (Invitrogen), as previously described (2) .
cAMP studies. The intracellular cAMP levels in HEK293 cells were measured to assess transfected ␣ 2C-AR WT and ␣2C-AR-1-5 MUT cell surface association and function. Cyclic AMP levels were quantitated using 125 I-radioimmunoassay kit (Biomedical Technologies, Stoughton, MA) as previously described (19) . Duplex-3. The duplex-3 targeting sequence was CACCTTCAC-TATTGTCACCAA (nt 5535-5555, relative to the A of the translation start site).
Duplex-4. The duplex-4 targeting sequence was CCGCGCCAG-CATGATGAACAA (overlapping the translation start site, 10 nt noncoding and 11 nt coding).
Duplex-5. The duplex-5 targeting sequence was CAAGGTG-GATATCACCTACGA (nt 3105-3125, relative to the A of the translation start site).
The nonsilencing siRNA duplex with target sequence AATTCTC-CGAACGTGTCACGT that shows no known homology to mammalian genes using BLAST (and shows 16-base overlap with Thermotoga maritima bacteria) was used as control.
The siRNA duplexes were transfected in equimolar concentrations in human microVSM by electroporation (Amaxa nucleofection) or by magnetic nanoparticle-assisted delivery (IBA, St. Louis, MO). Various concentrations of duplex-1 and -2, ranging from 178 to 535 pmol were utilized in imaging studies. For cAMP studies, magnetic nanoparticle-assisted delivery of fluorescein-labeled dsRNA oligomer (BLOCK-iT, Invitrogen) was utilized to test various concentrations (0 -100 pmol) to optimize delivery utilizing immunofluorescence microscopy. Using this approach we observed ϳ100% transfection efficiency with no cytotoxicity. Knockdown of filamin-2 was optimized with duplex-2, -4, and -5 (equimolar amounts, combined concentration of 100 pmol) and showed 19 Ϯ 3.8% inhibition compared with the equivalent concentration of control nonsilencing siRNA duplex (n ϭ 3; P Ͻ 0.01, determined by Western blot analysis using cells harvested ϳ65 h after siRNA delivery). This level of knockdown was sufficient to elicit a noticeable effect on receptor function.
Similarly, studies in HEK293 cells established the feasibility of using combination of silencing duplex-1, -3, and -4 (equimolar amounts, combined concentration of 480 pmol) to effectively knockdown filamin-2 (62% Ϯ 10% inhibition compared with equivalent concentration of control nonsilencing siRNA duplex; n ϭ 3; P Ͻ 0.05, determined by Western blot analysis).
Western Blot Analyses
Visualization of proteins of interest was performed as previously described (12, 19) . Samples were separated on 10% SDS-PAGE for ␣ 2C-AR or 8% SDS-PAGE for filamin. Samples were incubated at 37°C for 2 h (for ␣2C-ARs) or at 95°C for 10 min (for filamin) before loading.
Microscopy
Immunofluorescence-confocal microscopy and quantitation of fluorescence. This was performed on microVSM as described previously (19) . The optical slices obtained by this approach allowed spatial visualization of intracellular and cell surface ␣ 2C-ARs (referred to as cell boundary, which includes surface and subsurface receptors). For fluorescence comparisons, the highest intensity observed was used as reference for each set of experiments and identical settings and conditions were used to capture and process all images. For assessing changes in mean fluorescence intensity, the region-ofinterest tool (NIS-Elements AR Laboratory Image Analysis System; Nikon Instruments, Melville, NY) was used for quantitation for each set of experiments. The quantitation of mean fluorescence intensity of ␣ 2C-ARs at the cell boundary was assessed at four different regions of the cell boundary per cell.
␣2C-AR-GFP live cell studies. Nucleofected quiescent human microVSM on glass bottom culture dishes (MatTek, Ashland, MA) were treated with 8-pCPT-2=-O-Me-cAMP (100 M, time, t ϭ 0) and placed in a stage top incubator (Tokai Hit) with temperature controlled at 37°C and 5% CO 2 flow. Images were collected at 10-min intervals for 9 h using the Nikon Eclipse Ti fluorescence microscope (ϫ40 objective; NIS Elements Imaging Software). To adjust for drift and to automatically maintain focus on a point of interest during In WT and mutant receptors, an HA tag is at the NH2 terminus and is therefore in the extracellular domain of cell surface receptors. Forty-eight hours after transfection, cells were either lysed and processed for total cellular expression of ␣2C-ARs or processed via live-cell labeling to detect cell surface receptors. Briefly, the cells were labeled with anti-HA antibody, and the cell-surface ␣2C-ARs subsequently were immunoprecipitated from cell lysates with protein-A/G-Sepharose beads and then subjected to SDS-PAGE followed by Western blotting. Data were normalized to the total ␣2C-ARs expression (not shown). Data are expressed as means Ϯ SE (n ϭ 4; P Ͻ 0.05). B: intracellular cyclic AMP was measured in transiently transfected HEK293 cells treated with the ␣2-AR agonist UK 14,304 (UK; 1 min, 10 pM-10 nM), followed by adenylyl cyclase stimulation by forskolin (FSK; 3 M, 5 min). The data are corrected for the baseline value and are presented as a percentage of the response to FSK alone, and expressed as means Ϯ SE; n ϭ 3 independent experiments measured in duplicate; *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001, ****P Ͻ 0.0001. image collection, the Perfect Focus System was used (Nikon Instruments). Differential interference contrast images were also obtained with the same microscope.
Quantitative immunofluorescence assessment of surface receptors. These experiments utilized amino-terminal HA-tagged ␣ 2C-ARs. Receptors on the cell surface will have the amino terminus in the extracellular region and be accessible to anti-HA antibody binding. This approach therefore allowed quantitative assessment of cell surface vs. subsurface receptors. Cells were cotransfected with HA-␣ 2C-AR-1-5 MUT (3.5 g) and pmaxGFP (0.5 g; Amaxa nucleofection); or HA-␣2C-AR WT (3.5 g), pmaxGFP (0.5 g), and 100 nM of control nonsilencing RNA; or HA-␣2C-AR WT (3.5 g), pmaxGFP (0.5 g), and 100 nM of filamin-2 (FLN 2) siRNA 2, 4, and 5 in equimolar concentrations. Quiescent cells were treated with the EpacRap1 activator 8-pCPT-2=-O-Me-cAMP (100 M) for the indicated time intervals and fixed in 3% paraformaldehyde. Nonpermeabilized human microVSM were stained with anti-HA (1:200 dilution) followed by secondary Alexa Fluor 568 goat anti-mouse IgG (1:200 dilution, red) and Hoechst nuclear stain (blue). Quantitation of mean fluorescence intensity of cell surface ␣ 2C-ARs in GFP-positive cells was assessed at four different regions of the cell boundary per cell using the region-of-interest tool (NIS-Elements AR Laboratory Image Analysis System).
Statistical Analysis
Statistical analysis of the data was performed by Student's t-test for either paired or unpaired observations. When more than two means were compared, either a one-way ANOVA with Bonferroni or Dunnett's post hoc test for multiple comparisons or a two-way ANOVA with Tukey-Kramer's post hoc test (GraphPad Prism, San Diego, CA) was used to identify differences among groups. Data are presented as means Ϯ SE, where n equals the number of independent experiments or individual cells. Values were considered statistically different when P Ͻ 0.05.
RESULTS

Actin-Binding Protein Filamin-2 Interacts With ␣ 2C -ARs
To identify potential ␣ 2C -AR interacting proteins involved in receptor translocation, a yeast two-hybrid screen was performed under stringent selection conditions on a cDNA expression library derived from human microVSM using the last 20 amino acids (part of the cytoplasmic carboxy terminus) of ␣ 2C -AR as bait. This region contained a unique ␣ 2C -AR nonconserved arginine-rich region (amino acids 454 -458, R 454 -458 ) not present in ␣ 2A -or ␣ 2B -ARs (Fig. 1) .
The results showed a novel interaction with a fragment of the muscle isoform of the actin cross-linking protein filamin, also known as filamin-2, filamin C, or gamma filamin (gene bank accession no. AF146692). The interacting clone included amino acids 1979 -2128 of repeat 20, 78 amino acids of the muscle-specific insert (amino acids 2129 -2206), and a conserved phosphorylation site Ser 2113 ( Fig. 2A) . The screen also showed interactions with component of oligomeric Golgi com- plex (COG1) and ␣ 2B -mannosidase, consistent with endoplasmic reticulum-Golgi trafficking of ␣ 2C -ARs (6). For the purpose of this study, the novel ␣ 2C -AR-filamin interaction was further examined. Arteriolar VSM express detectable levels of ␣ 2A -AR and ␣ 2C -AR subtypes (9) . These subtypes were, therefore, further tested for filamin binding specificity. The yeast two-hybrid ␣-galactosidase assays were utilized to examine the role of ␣ 2 -AR C-tail region in interaction with filamin-2 (amino-acids 1979 -2206). These assays allow quantitation and relative comparison of the strength of protein-protein interactions. The ␣ 2A -AR WT, ␣ 2C -AR WT, and arginine to alanine mutations (␣ 2C -AR-1-5 MUT) regions were tested for filamin-2 interaction using this approach (Fig. 2B ). These interactions with the filamin-2 fragment were compared with pGBKT7 backbone vector interaction with the same filamin-2 fragment. The tumor-suppressor gene p53 shows strong protein-protein association with the viral protein SV40 large T-antigen (21, 40) . This p53 and SV-40 large T-antigen interaction was utilized as a positive control in these assays. The ␣ 2A -AR WT region showed basal activity comparable to pGBKT7 backbone vector interaction. The ␣ 2A -ARs are not regulated by cold temperature or by cAMP signaling and are ubiquitously expressed on the cell surface (9, 18) . In sharp contrast, the ␣ 2C -AR WT region showed strong interaction with filamin-2 ( Fig. 2B ; similar results were observed when Gal4 DNA-BD was also fused to the last 20 amino acids of ␣ 2C -AR). Interestingly, ␣ 2C -AR-1-5 MUT showed significant loss of specific interaction between the two regions (ϳ3-fold loss compared with WT, P Ͻ 0.05; Fig. 2B ). The activity of ␣ 2C -AR-1-5 MUT fragment was comparable to the control ␣ 2A -WT (P ϭ NS).
Filamin and ␣ 2C -ARs Co-IP
We tested the in vivo interaction between ␣ 2C -ARs and filamin using Co-IP assays. We previously demonstrated that Rap1A (constitutively active, Rap1A-CA) increased cell surface translocation of ␣ 2C -ARs in transiently transfected heterologous HEK293 cells (19) . Experiments were therefore performed to examine the association of ␣ 2C -ARs and filamin in these cells. Transient cotransfections and Co-IP in HEK293 cells showed that Rap1A-CA increased ␣ 2C -AR-filamin interaction (Fig. 3A, 2 .9 Ϯ 0.7 increase compared with control vector; no changes in total levels of filamin were observed). Experiments were also performed in human microVSM to examine endogenous receptor-filamin interaction. In these cells increased intracellular cAMP activates both the A-kinase and (Fig. 3C ).
␣ 2C -AR-1-5 MUT Localizes to the Cell Surface
The impact of the alanine mutations was assessed in HEK293 cells, which allow quantitation of cell-surface receptors and G i -coupled function (18, 19) . In these cells the WT ␣ 2C -ARs localize predominantly to the trans-Golgi network (18) . In contrast to WT receptors, when the arginine-rich sequence of the carboxy terminal was mutated to alanines (R 454 -458 to A 454 -458 , ␣ 2C -AR-1-5 MUT), the mutant receptor localized predominantly to the cell surface. The level of cell surface receptors was also quantitated by live cell labeling of receptor amino-terminal HA-tag, immunoprecipitation, and Western blot analysis. Although WT and ␣ 2C -AR-1-5 MUT transfectants exhibited similar levels of total ␣ 2C -AR expression, the level of ␣ 2C -AR-1-5 MUT at the cell surface was 3.0 Ϯ 0.6 (means Ϯ SE; n ϭ 4; P Ͻ 0.05)-fold higher than that of the WT (Fig. 4A) .
The functional consequences of the R 454 -458 to A 454 -458 mutation were evaluated by the G i -protein-mediated, ␣ 2C -AR-dependent inhibition of forskolin-stimulated intracellular cAMP accumulation. In WT ␣ 2C -AR-transfected cells, the ␣ 2 -AR agonist UK 14,304 (concentration range: 10 pM-10 nM) did not significantly affect the intracellular accumulation of cAMP stimulated by forskolin (3 M; Fig. 4Bi ; 94.9 Ϯ 11.8% with 10 nM UK 14,304 vs. forskolin alone; n ϭ 3; P ϭ NS), supporting intracellular retention of WT ␣ 2C -ARs. However, in HEK293 cells expressing ␣ 2C -AR-1-5 MUT, UK 14,304 (10 pM-10 nM) inhibited forskolin-stimulated cAMP accumulation in a concentration-dependent manner, showing highest inhibition at 10 nM ( Fig. 4Bii; 32 .03 Ϯ 3.64% vs. forskolin alone; n ϭ 3; P Ͻ 0.0001), supporting cell-surface association of ␣ 2C -AR-1-5 MUT, and showing that the mutations did not affect receptor coupling and function. There was no statistically significant difference in the effect of forskolin (3 M) to increase cAMP accumulation between WT and ␣ 2C -AR-1-5 MUT transfected cells.
Filamin and ␣ 2C -ARs Colocalize
Immunofluorescence studies utilizing confocal microscopy supported Co-IP results and showed colocalization of endogenous ␣ 2C -ARs and filamin on trans-cytoplasmic filaments and showed increased ␣ 2C -ARs on cell boundary in 8-pCPT-2=-O-Me-cAMP-treated human microVSM (Fig. 5,  A and B) . Of note, the staining for ␣ 2C -ARs was punctate (vesicular), and these punctae appeared to be organized along the length of the filamin-decorated actin filaments (Fig. 5A, inset) . These results were in agreement with our previous study that showed increased association of ␣ 2C -ARs with F-actin (19) . Indeed, filamin colocalized with F-actin in 8-pCPT-2=-O-Me-cAMP-treated human microVSM (Fig. 5C) , consistent with the role of filamin as an actin-crosslinking protein.
Time Course of ␣ 2C -AR-GFP Receptor Translocation
Previous studies showed that cooling leads to rapid (within 60 min upon exposure to 28°C) translocation of functional ␣ 2C -ARs to the cell surface (2, 3, 7, 18) . Live-cell imaging experiments were therefore performed to examine the time course of receptor translocation at physiological 37°C upon stimulation of quiescent ␣ 2C -AR-GFP nucleofected human microVSM with the Epac-Rap1 activator 8-pCPT-2=-O-Me-cAMP (100 M; t ϭ 0 min; Fig. 6 ). Using this approach showed that translocation is a slower process and that the ␣ 2C -AR-GFP begins detectable translocation at ϳ175 min after Epac-Rap1 stimulation. This process continues over time with increased receptor at the cell boundary (Fig. 6, t ϭ 175 min to t ϭ 555 min) .
Filamin-2 and ␣ 2C -AR Translocation
Live-cell labeling of receptor amino-terminal HA-tag, immunoprecipitation, and Western blot analysis were performed to assess the role of filamin-2 in Rap1A-mediated ␣ 2C -AR cell-surface translocation in HEK293 cells.
Filamin-2 was knocked-down using siRNA. Indeed, filamin-2 knockdown inhibited Rap1A-mediated cell surface ␣ 2C -ARs ( Fig. 7A ; P Ͻ 0.01; n ϭ 3). These results were consistent in human microVSM using immunofluorescence confocal microscopy and colocalization with GFP-tagged ␣ 2C -ARs and filamin-2 siRNA duplexes (one duplex having 3=-AlexaFluor-647 label). The ␣ 2C -AR-GFP localized to the perinuclear region in quiescent cells treated with solvent (control). However, in cells treated with 8-pCPT-2=-O-MecAMP (100 M, 8 -9 h, time showing increased receptor at the cell boundary using immunofluorescence and live-cell imaging; Figs. 5, A and B, and 6), ␣ 2C -AR-GFP was present on the cell boundary in addition to intracellular vesicular compartments; this intracellular vesicular compartment localization of ␣ 2C -AR-GFP was clearly observed in microVSM using differential interference contrast-fluorescence imaging (Fig. 7, B and C) . In microVSM with siRNA filamin-2 duplexes, the ␣ 2C -AR-GFP cell boundary localization was not seen (Fig. 7B) . Indeed, knockdown of filamin-2 significantly reduced endogenous ␣ 2C -ARs on the cell boundary (Fig. 7, D and E) , consistent with ␣ 2C -AR-GFP studies.
Experiments were also performed to assess cell surface-associated vs. subsurface receptors in human microVSM. These experiments utilized amino-terminal HA-tagged ␣ 2C -ARs. Receptors on the cell surface in nonpermeabilized cells will have the amino terminus in the extracellular region and be accessible to anti-HA antibody binding and immunofluorescence-microscopy analysis. This approach therefore allowed quantitative assessment of cell surface vs. subsurface receptors in transfected quiescent microVSM treated with the Epac-Rap1 activator 8-pCPT-2=-O-Me-cAMP over various time intervals (0 -540 min). Studies with HA-␣ 2C -AR-1-5 MUT in nonpermeabilized microVSM showed cell surface-association, in agreement with HEK 293 studies (Fig. 7F) . Variable levels of surface receptors were noted upon stimulation of microVSM with 8-pCPT-2=-O-Me-cAMP (0 -360 min; Fig. 7G) . A significant drop in surface receptors, however, was observed upon prolonged treatment (540 min; Fig. 7G , mean fluorescence intensity of 18.92 Ϯ 4.2 vs. 95.96 Ϯ 9.5 at 0 min, P Ͻ 0.0001). In contrast, the levels of surface-associated HA-␣ 2C -AR WT receptors, examined in the presence of control nonsilencing RNA, showed a slight, yet significant, and transient increase between 0 and 120 min (mean fluorescence intensity of 57.64 Ϯ 9.05 at 60 vs. 36.8 Ϯ 5.2 at 0 min, P Ͻ 0.05, not detected in ␣ 2C -AR-GFP live-cell imaging studies), followed by a significant and sustained increase at 180 -540 min vs. 0 min (Fig. 7H , mean fluorescence intensity of 84.8 Ϯ 9.34 at 540 min vs. 36.8 Ϯ 5.2 at 0 min, P Ͻ 0.0001, detected similarly in ␣ 2C -AR-GFP live-cell imaging studies). These observations suggest increased cell surface translocation of intracellular receptors. This profile with HA-␣ 2C -AR WT receptors, however, was not observed in cells with filamin-2 siRNA (Fig. 7I) . In these cells a significant reduction in surface-associated receptors was observed with 8-pCPT-2=-OMe-cAMP (P Ͻ 0.05 at 60 -120 min, and 540 vs. 0 min; mean fluorescence intensity of 26.14 Ϯ 3.9 at 540 min vs. 41.9 Ϯ 2.0 at 0 min). These results were similar to the immunofluorescence imaging studies (Fig. 7, D and E) and suggest that the receptor does not translocate to the cell surface and remains intracellular.
Consistent with these observations, knockdown of filamin-2 impaired receptor function, supporting intracellular retention of ␣ 2C -ARs, assessed by ability of cell surface activated receptors to inhibit intracellular cAMP produced by adenylyl cyclase stimulation by forskolin (P ϭ NS) at all concentrations of the 
Rap1A-Rho-ROCK and Filamin-2 Ser 2113
We recently demonstrated the role of Rap1A-Rho-ROCK signaling in ␣ 2C -AR translocation to the cell surface in transiently transfected HEK293 cells (19) . The constitutively activated form of Rap1A (Rap1A-CA) increased cell surface receptors. This effect of Rap1A was inhibited by the ROCK inhibitor fasudil. Experiments were therefore performed to examine the role of Rap1A-Rho-ROCK in receptor translocation by filamin-2.
The filamin-2 interacting region identified in this study harbors a conserved serine at amino acid position 2113 (Ser 2113 ; Fig. 2A ). The phosphorylation of this filamin-2 Ser 2113 has been shown to be necessary and sufficient for actin reorganization in non-VSM (41, 44) . The role of Rap1A in this phosphorylation, however, was not previously examined. The studies therefore examined the effect of Rap1A-CA on filamin-2 Ser 2113 phosphorylation status in the absence or presence of fasudil (3 M) in HEK293 cells. Indeed, Rap1A-CA significantly increased Ser 2113 phosphorylation, which was inhibited by fasudil (2.17 Ϯ 0.51 with solvent control vs. 0.84 Ϯ 0.15 with fasudil; n ϭ 4 -5; P Ͻ 0.05; Fig. 8, A and B) .
To directly examine the role of Rap1A in filamin-2 Ser 2113 phosphorylation we utilized murine microVSM that were deficient in Rap1A (Rap1A Ϫ/Ϫ or Rap1A-null). We previously utilized these cells to show that Rap1A is necessary for ␣ 2C -AR expression and translocation (19) . Rap1A-null microVSM showed significantly reduced receptor expression and lacked Rho-mediated F-actin formation compared with control WT cells. The expression and translocation could be rescued by introducing Rap1A-CA in the Rap1A-null background (19) . Forskolin (10 M, 0 -16 h) increased filamin-2 Ser 2113 phosphorylation, with highest induction at 16 h in control WT (Rap1A ϩ/ϩ ) cells (Fig. 9, A and B) . This effect of forskolin was absent in Rap1A-null cells, which showed significantly decreased levels of filamin-2 Ser 2113 phosphorylation (Fig. 9, A and B) . Indeed, rescue studies that involved introduction of Rap1A-CA in these cells showed increased filamin-2 Ser 2113 phosphorylation (3.9 Ϯ 0.35-fold increase compared with control vector; n ϭ 4; P Ͻ 0.01). Similarly, introduction of Rap1A-CA in human microVSM showed increased filamin-2 Ser 2113 phosphorylation (1.9 Ϯ 0.17-fold increase compared with control vector; n ϭ 8; P Ͻ 0.001). Together, these studies showed that Rap1A is necessary for filamin-2 Ser 2113 phosphorylation in murine and human microVSM. Indeed, the regulation of ␣ 2C -AR expression and translocation is remarkably similar in these cells (19) .
Imaging studies were performed to examine the spatial distribution of filamin-2 phospho-Ser 2113 and to quantitate mean fluorescence intensity as a measure of phosphorylation status. In murine microVSM stimulated with the Epac-Rap1 activator 8p-CPT-2=-O-Me-cAMP (100 M, 9 h), increased levels of filamin-2 phospho-Ser 2113 were detected on filaments and on the cell boundary in WT cells (Fig. 10, A and B) . This pattern of filamin-2 phospho-Ser 2113 increase and distribution was not seen in Rap1A-null microVSM (Fig. 10, A and B) . However, introduction of constitutively activated Rap1A (Rap1A-CA) in Rap1A-null microVSM showed a significant increase in filamin-2 phospho-Ser 2113 intensity and distribution on filaments, which was inhibited by fasudil (Fig. 10, C and D) . Similarly, in human microVSM stimulated with 8pCPT-2=-OMe-cAMP (100 M, 9 h), the increased intensity and filament associations were inhibited by fasudil (Fig. 10, E and F) . Finally, the effect of fasudil on receptor function was tested in human microVSM (assessed by ability of cell surface activated receptors to inhibit intracellular cAMP produced by adenylyl cyclase stimulation by forskolin). Compared with solvent control (vehicle), the ␣ 2C -AR function was impaired in the presence of fasudil, consistent with the role of Rap1A-Rho-ROCK signaling in filamin-2 Ser 2113 phosphorylation and intracellular retention of ␣ 2C -ARs ( Fig. 10G ; 54.25 Ϯ 6.03% with 10 nM UK 14,304 vs. forskolin alone in vehicle control, P Ͻ 0.0001 (i), compared with (ii) 87.75 Ϯ 10.08% with 10 nM UK 14,304 vs. forskolin alone in presence of fasudil, P ϭ NS).
DISCUSSION
In this study we demonstrate that the actin-binding protein filamin-2 associates with microVSM ␣ 2C -ARs and that this interaction plays a vital role in cell surface receptor translocation. We confirmed the specificity of this interaction by Co-IP and colocalization studies in human microVSM and by a live-cell labeling and immunoprecipation approach in heterologous HEK293 cells. These findings extend our previous observations that identified a role of F-actin in receptor translocation. Indeed, filamin colocalized with F-actin, and knockdown of filamin-2 impaired cell surface ␣ 2C -AR translocation and function. These studies show that interaction with filaminactin is necessary for translocation and for proper function of microVSM ␣ 2C -ARs and provide a mechanism of receptor translocation by actin.
The filamin-2 interacting region identified in this study harbors a conserved serine at amino acid position 2113 (Ser 2113 ). This serine is a physiologically important residue and phosphorylation of this residue plays a key role in actin reorganization in non-VSM (41, 44) . In this study we demonstrate that phosphorylated filamin-2 phospho-Ser 2113 is primarily associated with filaments and plasma membrane, consistent with previous studies in non-VSM. We further show that Rap1-Rho-ROCK signaling is necessary for the phosphorylation of filamin-2 Ser 2113 in microVSM. Inhibition of this signaling by the ROCK inhibitor fasudil inhibited phosphorylation and filament distribution and impaired ␣ 2C -AR receptor function. Filamin, therefore, has a role in increased cell surface translocation of this GPCR in microVSM. We previously demonstrated that the Ras-related small GTPase Rap1A, in addition to transcriptionally increasing ␣ 2C -AR expression, also enhances translocation of ␣ 2C -ARs to the cell surface. Our results suggested that ␣ 2C -AR expression and translocation were independent and involved two separate processes. The effect of Rap1 on translocation was mediated through the activation of Rho-ROCK signaling and the actin cytoskeleton (19) . In human microVSM increased levels of intracellular cAMP or exogenous addition of the cAMP analog 8-p-CPT-2=-O-cAMP activated Rap1, leading to subsequent activation of RhoA and ROCK (Rho-ROCK) (8, 19) . Rap1-Rho-ROCK increased F-actin and facilitated cell surface receptor translocation on actin filaments (19) . This mechanism of regulation is not seen for ␣ 2A -ARs, which do not show proteinprotein interaction with filamin-2, are not influenced by Rap1 signaling, and are ubiquitously expressed on the cell surface.
Together, our studies show that Rap1-Rho-ROCK-filamin-2 signaling regulates redistribution of functional ␣ 2C -ARs and explains the increased association of the receptor with filamin-2 upon Rap1 activation. This mechanism is summarized in Fig. 11 .
The presence of putative motifs in close proximity in part of the transmembrane 7 and carboxy terminus of ␣ 2C -AR (last 30 amino acids; Fig. 1 ) suggests multiple roles in receptor mobilization. For example, the NPXXYXXF motif has an important structural role, and depending on the particular GPCR, may contribute to Golgi network targeting, cell surface targeting, and endocytosis-internalization signals. The FXXXFXXXF motif encodes an endoplasmic reticulum (ER) export signal facilitating cell surface expression (4, 37) . The ␣ 2C -AR also contains a unique arginine-rich region (RRRRR). When fused to heterologous receptors, the ␣ 2C -AR (RRRRR) has a dominant-negative effect and functions as a potent ER-Golgi retention sequence, overriding ER export signals in K ϩ channels (27, 33) . Mutating all five arginines to alanines released this effect and led to cell surface expression (33) . Similar argininebased motifs function as ER retention and retrieval signals in other receptors (5, 29, 36, 45, 46) . In combination with the ER export motif in ␣ 2C -ARs, the arginine-rich region may mediate regulated delivery to the cell surface under certain physiological stimuli. For example, intracellular vesicle-mediated delivery coupled to cAMP-Rap1-Rho-ROCK-filamin-2 signaling seen in our studies. Indeed, mutation of all five arginines to alanines leads to loss of interaction with filamin-2 and to cell surface expression of functional receptors. Our studies, therefore, identify the last 14 amino acids of ␣ 2C -AR, harboring the (RRRRR) region, to be critical for filamin-2 interaction and regulated (vs. constitutive) delivery to the cell surface. In the unbound state, (RRRRR) may dominate over the adjacent conserved GPCR export signal FXXXFXXXF, thus retaining and accumulating mature intracellular ␣ 2C -ARs. The filamin-2-␣ 2C -AR interaction links the actin cytoskeleton in mobilizing the receptor to the plasma membrane. Binding of filamin-2, an actin-binding protein, may unmask the export signal, releasing the receptor to the plasma membrane.
The findings in this study have broader implications for understanding biological mechanisms in cAMP signaling as well as thermoregulation. Divergent signaling pathways may converge on Rho-ROCK-filamin-2 to mediate receptor translocation and function. For example, the ␣ 2C -ARs have a known physiological role in human and murine cutaneous circulation response to cold temperatures (7, 17, 38) . Moderate cooling to 28°C leads to increased biological activity of arteriolar ␣ 2C -ARs and to vasoconstriction. The mechanism identified includes cooling triggered release of mitochondrial reactive oxygen species, RhoA and ROCK activation, and cell surface translocation of functional ␣ 2C -AR (2, 3) . This physiological response to cooling reduces loss of body heat and directs blood to vital organs to sustain a normal body core temperature (42) . The findings in this study suggest cooling-triggered Rho-ROCK activation, phosphorylation of filamin-2 Ser 2113 , and ␣ 2C -AR cell surface translocation to be linked. Whether cooling mediates this effect on ␣ 2C -ARs through Epac-Rap1-Rho-ROCK pathway activation remains unknown. Further studies utilizing Rap1A-null microVSM will allow examination of this possibility. Altogether, the vital role of the ␣ 2C -AR COOH terminus in receptor translocation identified in this study suggests the physiological relevance of this region in thermoregulation. The ␣ 2C -ARs may have evolved to allow warm blooded, vs. coldblooded, species to thermoregulate. Further studies are required, including phylogenetic analysis, which may shed light on the evolutionary significance of this region in mammals.
The Epac-Rap1A-Rho-ROCK-␣ 2C -AR pathway identified in our studies may be activated at physiological temperature in certain individuals manifesting the peripheral vascular condition of cold feet and cold hands (30) . Further, this pathway is activated by increased intracellular cAMP, triggered by byproducts of inflammation (8) , and may contribute to disease progression and severity in individuals with the peripheral vascular disorder of Raynaud's phenomenon. A deeper molecular understanding of ␣ 2C -AR-filamin-2 protein-protein interaction using computational modeling and prediction approaches (molecular docking studies) may enable testing of novel targeting approaches to disrupt this interaction and thereby receptor cell surface translocation. For example, decoy peptide or small molecule inhibitor interference, with potential therapeutic applications.
In non-VSM, filamin is necessary for proper biological activity of other GPCRs. For example, filamin is required for proper cell surface expression and function of dopamine D2 and D3 receptors, calcium-sensing receptors, metabotropic glutamate receptor type 7 (mGluR7), and calcitonin receptors, where filamin acts as a scaffolding protein to anchor receptor and signaling molecules and facilitates receptor stability and recycling from endosomes (1, 13, 16, 22-24, 34, 47) . Other roles described for filamin include directing trafficking of the endoprotease furin in the trans-Golgi network/endosomal system and processing of furin substrates in the endocytic pathway (25) , and a role in opioid receptor agonist-induced downregulation and desensitization (31) .
Filamin is also known to play an important role in human development and disease. The muscle-specific subtype filamin-2 has a role in structural support and assembly of signaling complexes including sarcoglycan and contributes to skeletal muscle integrity and signaling complex necessary for muscle function. Filamin-2, therefore, plays a role in skeletal muscle dystrophy, including limb girdle muscular dystrophy (39) . Indeed, the first disease-related mutation (W2710X, tryptophan to stop codon, repeat 24, dimerization domain, see Fig. 2A ) was described in filamin-2 causing autosomal dominant myofibrillar myopathy (MFM, referred to as an autosomal dominant filaminopathy, a form of MFM; Ref. 43 ). This mutation contributes to a truncated protein that lacks the ability to dimerize correctly. This mutation, therefore, contributes to mislocalization, disruption of dimerization, and aggregate formation of filamin-2 in skeletal muscle fibers. The clinical and molecular features of this mutation resemble limb-girdle muscular dystrophy and MFM (43) . Additional mutations in filamin-2 (re- Fig. 11 . Proposed intracellular signaling mechanism coupled to ␣2C-adrenoceptor (␣2C-AR) expression and translocation in microVSM. Signaling molecules Rap1A and RhoA-ROCK implicated in ␣2C-AR expression and translocation in response to increased intracellular cAMP in human microVSM. According to this model activation of Rap1 by cAMP is sufficient for ␣2C-AR expression, loading to filaments, and translocation to the cell surface. Cell surface ␣2C-ARs elicit vasoconstriction to the endogenous agonist norepinephrine or the synthetic agonist UK-14,304. EPAC, exchange proteins directly activated by cyclic AMP; ROCK, RhoA kinase; JNK, c-Jun amino-terminal kinase; RRRRR, the arginine-rich region (R 454 -458 ) within the last 14 amino acids of ␣2C-AR carboxy terminus. Phosphorylation (P) of filamin-2 Ser 2113 is necessary for receptor deployment to the cell surface. 8-pCPT-2=-O-Me-cAMP, a synthetic cAMP analog that selectively activates EPACRap1 signaling.
ferred to as filaminopathies, that belong to a subgroup of MFM) have since been identified and include 1) a frame shift deletion resulting in premature stop codon and nonsensemediated mRNA decay, altogether leading to partial loss of filamin-2 protein (filamin-2 haploinsufficiency; causing distal myopathy; Ref. 14); 2) in frame 12 nucleotide deletion in repeat seven that removes four amino acids, leading to aggregation of filamin-2 (in MFM patients; Ref. 35); 3) deletion of six amino acids and insertion of two amino acids in frame in repeat seven, leading to protein accumulation (26) ; and 4) NH 2 -terminal missense mutations leading to increased association with F-actin and increased potential to aggregation (distal myopathy; Ref. 11). The in vivo effects of filamin-2 mutations on vascular ␣ 2C -AR function remain unknown. It is possible that loss in filamin-2 function may contribute to loss of ␣ 2C -AR receptor translocation to the membrane. Further work will need to be performed to test this possibility.
